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doi:10.1016/j.ejvs.2008.07.009Abstract Objectives: Report the New Zealand national experience of endovascular repair of
acute traumatic thoracic aortic injuries (TTAIs).
Design: Retrospective analysis of the New Zealand thoracic aortic stent database between
December 2001 and December 2007.
Materials and methods: Of the 134 patients on the database, 27 patients (20%) underwent en-
dovascular repair of TTAI. Data collected included age, sex, cause of injury, details of the
procedure, complications and mortality.
Results: Most patients were young, median age 20 (15e78), male (nZ 19, 70%), and involved
in motor vehicle accidents (nZ 23, 85%). Median length of aorta stented was 117 mm (77e
200 mm). Great vessel origins were covered intentionally in 23 (85%) patients, four (17%)
requiring a hybrid procedure. Average procedure time was 98.3 min (35e180). Primary tech-
nical success was 96%, secondary technical success 100%. Endoleaks were observed in four
(15%) patients, one requiring a second endovascular procedure. There were no conversions
to open surgery. Procedure-related complications occurred in four (15%) patients. No patient
developed cord injury. All cause mortality at 30 days is one (4%) and at discharge is two (7%)
due to associated poly-trauma.
Conclusion: Our results add further evidence of the safety of endovascular repair of thoracic
aortic injury and compare favourably with those of other centres.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.3 364 0913; fax: þ64 3 364
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Traumatic injury to the thoracic aorta (TTAI) is a condition
with very high mortality. At the scene of the accident, 85%
of patients die from exsanguination.1 Of the 15% that
survive and make it to hospital, 33% die within the first 6 h2
and most die within a few days from rupture.1 After headd by Elsevier Ltd. All rights reserved.
Table 1 Number of patients with TTAI treated in the
different centres contributing to the NZ TAS database
Centre Number of patients
Auckland Hospital, Auckland 10 (37%)
Christchurch Hospital, Christchurch 4 (15%)
Dunedin Hospital, Dunedin 0
Greenlane Hospital, Auckland 5 (18%)
Waikato Hospital, Hamilton 7 (26%)
Wellington Hospital, Wellington 1 (4%)
Endovascular Repair Acute Thoracic Aortic Injury 531injury, TTAI is the most common cause of death from blunt
injury.3
Open surgical repair has been the traditional method of
treating TTAI with thoracotomy and interposition of an
aortic conduit. This carries significant risk with mortality as
high as 30%.4 In addition, there is significant morbidity such
as cord injury which is seen in up to 19% of patients after
surgical repair.4 With the introduction of endovascular
techniques to repair the aorta, there has been a shift in the
management of these patients away from open surgery
toward aggressive management of blood pressure and
endovascular repair of the aorta.5
In New Zealand, endovascular repair of the thoracic
aorta has been recorded on a national database since 2001.
The aim of this study was to analyse the data available to
date and compare the results in New Zealand with other
centres from around the world.
Materials and methods
The New Zealand thoracic aorta stent database (NZ TAS)
began data collection in December 2001. It involves collab-
oration between the six centres across New Zealand carrying
out endovascular repair of the thoracic aorta. The centres
are Auckland Hospital, Christchurch Hospital, Dunedin
Hospital, Greenlane Hospital in Auckland, Waikato Hospital
in Hamilton, and Wellington Hospital. A standardised form is
filled in for each patient at the time of implantation.
Completed forms are sent to Christchurch Hospital where
the data are collated and added to the central electronic
database. In addition to this, a paper copy of all entries is
stored for back up. The database is administered by The
Vascular Society of New Zealand. Ongoing funding is from an
agreed fixed sum of money contributed by the company
supplying each stent graft on a case-by-case basis. None of
the supplier companies contributed to the study itself.
The NZ TAS database was retrospectively analysed
between December 2001 and December 2007. This has been
approved by the ethical committee of our institution. Of
the 134 patients on the database, 27 patients (20%) had
TTAI treated acutely (within 14 days of injury) by endo-
vascular repair. Outcome measures included primary tech-
nical success (exclusion of the injured segment of aorta
during the initial procedure), secondary technical success
(exclusion of the injured segment of aorta required further
intervention after the initial procedure), graft-related
complications, procedure-related complications/mortality
and post-procedure complications/all cause mortality up to
30 days after the procedure.
Results
Nineteen patients (70%) were male and eight patients (30%)
female. Mean age of the patients was 34 years, median age
20 years (15e78). TTAI was sustained as a result of motor
vehicle accident (MVA) in 23 patients (85%). Of the
remaining four patients, three (11%) had fallen from
a height and one (4%) had been crushed. Surgery was not
felt to be survivable in 12 (44%) patients due to the severity
of their co-existing poly-trauma. The details of the co-
existing injuries are not available from the database.Patients were admitted to one of the six participating
centres for treatment (Table 1). Diagnosis was made using
computed tomography (CT) with multiplanar reconstruc-
tions. These images were used to plan the procedure and
select the correct size of stent graft to deploy. In addition,
imaging of the neck and cerebral circulation was performed
in order to determine if an extra-anatomical bypass would
be needed as part of the procedure. In all cases, the stent
graft was deployed with the patient under general anaes-
thetic. Most procedures were carried out as combined cases
by an interventional radiologist or cardiologist and
a vascular or cardiothoracic surgeon in the interventional
radiology suite. The time between the traumatic injury and
endovascular repair of the aorta ranged from 0 to 4 days,
mean 12 h.
Vascular access was gained through a common femoral
arteriotomy in all but one patient (96%), the other patient
requiring exposure of the right common iliac artery by an
extra-peritoneal approach due to the small size (5 mm) of
the common femoral arteries. Right brachial artery punc-
ture was also carried out in 16 patients (59%) to allow
imaging of the left subclavian artery origin thereby aiding
accurate placement of the proximal graft.
Standard technique was used to deploy the stent grafts
following manufacturer guidelines. Graft oversizing was not
formally recorded on the database but had been noted for
14 patients (52%). The mean oversizing for the stents used
in these 14 cases was calculated at 26.3% in these stent
grafts (median 26.5%, range 9e50%). Twenty-two patients
(82%) received Cook Zenith stents (William A. Cook Aus-
tralia Pty Ltd, Brisbane, Australia; Obex Medical Ltd,
Auckland, New Zealand) and five patients (18%) received
Medtronic Talent stents (Medtronic Australasia Pty Ltd,
Auckland, New Zealand). The mean length of aorta covered
by stent graft was 110 mm, median 117 mm (77e200). Most
patients (89%) required deployment of only one stent but
two patients (8%) required two stents and one patient (4%)
required three stents. Average procedure time was 98 min,
median 94 min (35e180).
In order to obtain an adequate seal above the site of
aortic injury, great vessel origins were covered intention-
ally in 23 (85%) patients (Table 2). A planned extra-
anatomic bypass procedure was carried out in three (17%)
of these patients. In one patient, pre-operative evaluation
of the cerebral circulation led to a right common carotid to
left subclavian bypass prior to the endoluminal procedure.
In one patient, the trauma involved the transverse aorta to
the level of the origin of the innominate artery, such that
a de-branching procedure with moving of the origins more
proximally was performed prior to the endoluminal
Table 2 Great vessel origins intentionally covered by the
stent graft
Great vessel origin covered Number of patients
None 4 (15%)
Left subclavian artery only 18 (66%)
Left subclavian and left common
carotid arteries
3 (11%)
Left subclavian and aberrant left
vertebral arteries
1 (4%)
Aberrant right subclavian artery 1 (4%)
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formed in one patient. Two patients had anatomical vari-
ations in which the origins of an aberrant left vertebral and
aberrant right subclavian artery were intentionally covered
without consequence.
Primary technical success was achieved in 26 patients
(96%). Secondary technical success was 100%. Endoleaks
were observed in four patients (15%). Three of these had
a proximal type 1 endoleak and one patient had a type 2
endoleak from the left subclavian artery that had been
covered during the primary procedure. Of the patients with
type 1 endoleaks, one underwent successful exclusion the
day after the primary procedure, one resolved spontane-
ously and the other was discharged without further treat-
ment (no data are available to know if this endoleak
persists). Although not formally recorded on the database,
graft oversizing data were available in two of these patients
and varied from 13 to 15%. The type 2 endoleak resolved
spontaneously without the need for further intervention.
There were no complications related to the graft itself
however, mal-deployment of the top end of the graft
occurred in one patient. This patient had a left vertebral
artery origin between the left common carotid and the left
subclavian arteries. The intention was to cover the left
subclavian but not the left vertebral artery. Due to the mal-
deployment, the stent graft covered the left vertebral
artery origin and partially covered the left common carotid
artery origin. A right to left common carotid extra-
anatomical bypass was performed. No revascularisation of
the vertebral artery was performed without adverse
consequence.
Procedure-related complications were observed in four
patients (15%). Common femoral artery thrombosis
occurred in one patient requiring immediate thrombec-
tomy. In the second patient there was inadvertent occlu-
sion of the left vertebral artery (arch origin) and partial
occlusion of the left common carotid artery requiring
a right to left common carotid artery bypass graft. In the
third patient, there was no flow within the conduit of
a right to left common carotid artery bypass conduit
requiring re-exploration to restore patency. The fourth
patient had a posterior fossa haemorrhage prior to stent
graft implantation but was noted to have developed a new
low density area in the left posterior fossa on a follow up
scan that was not present on the pre-operative scan. This
was almost certainly as a result of occlusion of the left
vertebral artery but was asymptomatic. No deaths occurred
during the endovascular procedure.Other complications were observed in nine patients
(33%) and related to their poly-trauma. These included
pulmonary contusions with subsequent collapse/consolida-
tion, chest infection, atrial fibrillation, confusion, oliguria,
intra-abdominal haemorrhage and bile leak. No patients
developed paraplegia. Mean length of hospital stay after
the procedure was 24 days, median 23 days (3e42).
One patient died the day after stent graft implantation
from intra-abdominal haemorrhage due to multiple visceral
injuries related to their poly-trauma. All cause mortality at
30 days was therefore one (4%). A second patient died 59
days after the procedure from sepsis and complications
related to head injury. All cause mortality at discharge is
therefore 7%. No patient died from the thoracic aortic
injury as a result of the endovascular repair of the injured
aorta.Discussion
The population of patients who sustained TTAI in our group
is interesting when compared to the population of New
Zealand as a whole. There is a predominance of young
patients with median age of 20 years. Male patients
represent 70% of our population but in the 2006 population
census (www.stats.govt.nz) the estimate of male/female
ratio in New Zealand was 0.95. In addition, most patients
sustained their TTAI in a motor vehicle accident. The young
age of the patients presents a number of problems. The
aortic diameter is often smaller in these patients such that
correct graft sizing may be difficult. Most grafts are
designed to treat aneurysms of the thoracic aorta in which
the diameters are greater. Oversizing may increase the risk
of endoleak with wrinkles in the fabric. In our series, the
degree of oversizing in those patients with type 1 endoleaks
was 13e15%, well within the recommended limits of 10e
15%. In young patients, the stent graft is likely to remain in
situ for many years. The long-term durability of these grafts
is not known at present and may pose problems in the
future. In addition, there may be problems with long-term
monitoring the graft. This usually requires annual plain
films to look for graft migration and strut failure. The
patients may not comply with such monitoring and may be
lost to follow up. In addition, it is not clear what the
implications of graft migration or strut failure in these
patients are.
Our results compare favourably with the results from
other case series of similar size (Table 3),6e17 especially
when considering the relatively small number of patients
treated by each of the participating centres in our study
over the last 6 years. The comparison studies have a total of
256 patients treated for TTAI. Overall technical success is
99.2% (nZ 254), incidence of endoleak 6.6% (nZ 17),
paraplegia 1.6% (nZ 4), and mortality 8.6% (nZ 22). One
of the difficulties comparing these results is that most of
the authors do not distinguish between primary and
secondary technical success. This is an important measure
of outcome because of the obvious burden on resources and
the patient of having to have multiple procedures to obtain
successful exclusion of the aneurysm. Our 30-day mortality
is also very low particularly when considering the small
numbers of patients treated at each individual centre.
Table 3 Summary of results of case series with more than 10 patients in the last 5 years including our results for comparison
Author Year Number Success (%) Endoleak Cord injury Mortality
NZ TAS 2008 27 96 4 (15%) 0 1 (4%)
Neschis DG 2007 20 100 3 (15.8%) 0 4 (20%)
Orend KH 2007 34 100 4 (11.8%) 0 3 (8.8%)
Hoornweg LL 2006 28 100 1 (3.6%) 0 4 (14.3%)
Marcheix B 2006 33 100 3 (9.1%) 1 (3%) 0
Pratesi C 2006 11 100 0 0 1 (9.1%)
Tehrani HY 2006 30 100 0 0 2 (6.6%)
Peterson BG 2005 11 100 0 0 0
Leurs LJ 2004 50 96 0 3 (6%) 3 (6%)
Dunham MB 2004 16 100 0 0 1 (6.3%)
Karmy-Jones 2003 11 100 2 (18.2%) 0 3 (27.3%)
Lachat M 2002 12 100 1 (8.3%) 0 1 (8%)
Endovascular Repair Acute Thoracic Aortic Injury 533Endovascular repair is attractive in this group of patients
because the physiological stress on the patient is less. The
technique has been shown to have lower risk of death and
paraplegia and stroke when compared with open sur-
gery.18e24 Low rates of paraplegia are likely to be due to
the short length of aorta stented. The threshold for
increased risk of paraplegia appears to be 205 mm.25 None
of the patients in this series had stents greater than
200 mm. Another explanation is that the aorta is not cross-
clamped and there is no prolonged hypotension avoiding
long ischaemic time.26
In our series, most patients were treated within the first
12 h following injury. Timing of endovascular repair of TTAI
is a matter of debate. For open repair there is evidence
that delaying surgery until associated injuries have been
treated whilst maintaining aggressive blood pressure
management and close monitoring with imaging is associ-
ated with better outcomes.27,28 The timing of endovascular
repair appears to be less critical. Early treatment offers
advantages such as the ability to manage associated
injuries and stabilise the patient.29 Delayed endovascular
repair, however, allows more time to treat injuries that
may cause graft infection as well as coagulopathies.29
One of the limitations of our study is absence of data
regarding the number of patients treated with open surgery
during the time of our study and their outcome. A study by
Baguley et al. gives some insight.20 In their study, 29
patients were treated at Greenlane Hospital in Auckland
between 1995 and 2004. Of these patients, 30-day mortality
was 10%. In addition, complications included hemiplegia
(nZ 1) and recurrent laryngeal nerve palsy (nZ 5). One of
their patients underwent endovascular repair without
complication. This is the closest comparison group to our
study and provides further evidence of the safety of
endovascular compared to surgery.
The analysis of the NZ TAS database has highlighted some
weaknesses in the data collected by the NZ TAS database.
This includes lack of data regarding co-existing injuries in
the trauma patients and diameter of the stent graft
deployed (although the length was recorded). Both these
are to be addressed by simple modification of the data
collection forms. In addition to this, there are no data
regarding follow up beyond 30 days. Phase 2 of the database
will be to develop a method of collecting this information.Because of the multiple centres involved in the study,
we are dependent on the other centres providing informa-
tion on all the patients treated with endovascular repair.
One way to ensure all the patients who have had endo-
vascular repair of their thoracic aorta are entered onto the
NZ TAS database is to audit the manufacturer’s records of
stent grafts sold/deployed against the patients entered
into the NZ TAS database. Such an audit has been carried
out in Christchurch and Auckland hospitals demonstrating
100% concordance. At the current time, permission is being
sought from the remaining participating centres to
complete this audit.
Endovascular repair is well established in many major
trauma centres and there has been a shift in management
away from surgery toward endovascular repair.5 There are
no prospective randomised control trials comparing endo-
vascular with open repair of TTAI. It is unlikely that such
a trial will occur because the current data demonstrate
lower major adverse outcomes (such as mortality/cord
injury/stroke) in the endovascular patients compared with
open surgical repair.24 As a result, few clinicians have
clinical equipoise.30 The exact role of endovascular repair
remains to be determined but may be offered to all
patients, reserved for those patients who cannot be hep-
arinised, or used as a temporary fix with open surgery
carried out when the patients have fully recovered.24 This
could resolve the issue of long-term durability. In the
absence of level 1 evidence it is important that complete
and accurate data are kept so that decisions can be
evidence based. The NZ TAS registry makes a useful
contribution to this data set.
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